Too old to care?

Oncologist

Volumn 9, Issue 3, 2004, Pages 343-352

  Penson, Richard T ^a,b   Daniels, Kristy J ^a   Lynch Jr , Thomas J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Division of Hematology Oncology   (United States)

Author keywords

Age; Chemotherapy; Communication; Connection; Elderly; Oncology; Psychosocial; Support

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; ETOPOSIDE; PROTEIN P53; RETINOBLASTOMA PROTEIN; TELOMERASE;

AGED; AGING; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOGENESIS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUING EDUCATION; DOCTOR PATIENT RELATION; GERIATRIC PATIENT; HEAD AND NECK CANCER; HUMAN; LUNG CARCINOMA; LUNG SMALL CELL CANCER; MEDICAL DECISION MAKING; ONCOLOGY; PATIENT ATTITUDE; PATIENT COUNSELING; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; TERMINAL CARE; THORAX RADIOGRAPHY; TREATMENT INDICATION; TUMOR SUPPRESSOR GENE;

HEALTH CARE AND PUBLIC HEALTH; PROFESSIONAL PATIENT RELATIONSHIP;

AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; CARCINOMA, SMALL CELL; CAREGIVERS; FEMALE; HEALTH SERVICES FOR THE AGED; HUMANS; LUNG NEOPLASMS; PREJUDICE; PROFESSIONAL-PATIENT RELATIONS; SOCIAL SUPPORT;

EID: 2942584856     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.9-3-343     Document Type: Article

References (88)

1. Surveillance, epidemiology, and end results, National Cancer Institute. http://seer.cancer.gov/
2. Yancik R, Ries L. Cancer and age: magnitude of the problem. In: Balducci L, Lyman GH, Ershler WB, eds. Comprehensive Geriatric Oncology. London: Harwood Academic Publishers, 1997.
3. Yancik R, Ries LA. Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am 2000;14:17-23.
4. U.S. Census Bureau. http://www.census.gov/
5. Edwards BK, Howe HL, Ries LA et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002;94:2766-2792.
6. Ershler W. Cancer: a disease of the elderly. J Support Oncol 2003;1(suppl 2):5-10.
7. Balducci L, Extermann M. Cancer and aging. An evolving panorama. Hematol Oncol Clin North Am 2000;14:1-16.
8. Markson EW. Functional, social, and psychological disability as causes of loss of weight and independence in older community-living people. Clin Geriatr Med 1997;13:639-652.
9. Hebert R. Functional decline in old age. CMAJ 1997;157:1037-1045.
10. Wagner EH. Preventing decline in function. Evidence from randomized trials around the world. West J Med 1997;167:295-298.
11. Repetto L, Pietropaolo M, Gianni W. Comprehensive geriatric assessment in oncology: pro. Tumori 2002;88(suppl 1):S101-102; discussion S105.
12. Gronlund B, Hogdall C, Hansen HH et al. Performance status rather than age is the key prognostic factor in second-line treatment of elderly patients with epithelial ovarian carcinoma. Cancer 2002;94:1961-1967.
13. Extermann M. Assessment of comorbidity. Crit Rev Oncol Hematol 2000;14:63-78.
14. Fried LP, Storer DJ, King DE et al. Diagnosis of illness presentation in the elderly. J Am Geriatr Soc 1991;39:117-123.
15. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994;120:104-110.
16. Janssen-Heijnen ML, Schipper RM, Razenberg PP et al. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer 1998;21:105-113.
17. Tirelli U, Errante D, Van Glabbeke M et al. CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. J Clin Oncol 1998;16:27-34.
18. Verdery RB. Failure to thrive in old age: follow-up on a workshop. J Gerontol A Biol Sci Med Sci 1997;52:M333-M336.
19. Tinetti ME, Baker DI, McAvay G et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med 1994;331:821-827.
20. Inouye SK, Bogardus ST Jr, Charpentier PA et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999;340:669-676.
21. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
22. Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer 1997;80:1273-1283.
23. Fried LP, Bandeen-Roche K, Kasper JD et al. Association of comorbidity with disability in older women: the Women's Health and Aging Study. J Clin Epidemiol 1999;52:27-37.
24. Overcash J. Symptom management in the geriatric patient. Cancer Control 1998;5(suppl 1):46-47.
25. Inouye SK, Peduzzi PN, Robison JT et al. Importance of functional measures in predicting mortality among older hospitalized patients. JAMA 1998;279:1187-1193.
26. Reuben DB, Rubenstein LV, Hirsch SH et al. Value of functional status as a predictor of mortality: results of a prospective study. Am J Med 1992;93:663-669.
27. Siu AL, Morishita L, Blaustein J. Comprehensive geriatric assessment in a day hospital. J Am Geriatr Soc 1994;42:1094-1099.
28. Repetto L, Venturino A, Fratino L et al. Geriatric oncology: a clinical approach to the older patient with cancer. Eur J Cancer 2003;39:870-880.
29. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
30. Hahn WC, Weinberg RA. Modelling the molecular circuitry of cancer. Nat Rev Cancer 2002;2:331-341.
31. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-460.
32. Sherr CJ, DePinho RA. Cellular senescence: mitotic clock or culture shock? Cell 2000;102:407-410.
33. Hahn WC, Counter CM, Lundberg AS et al. Creation of human tumour cells with defined genetic elements. Nature 1999;400:464-468.
34. Tyner SD, Venkatachalam S, Choi J et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002;415:45-53.
35. Garcia-Cao I, Garcia-Cao M, Martin-Caballero J et al. "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J 2002;21:6225-6235.
36. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001;411:375-379.
37. Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med 1993;328:1237-1243.
38. Folkman J, Kalluri R. Cancer without disease. Nature 2004;427:787.
39. American Psychological Association, resolution on ageism. http://www.apa.org/pi/aging/ageism.html
40. Ayanian JZ, Zaslavsky AM, Fuchs CS et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 2003;21:1293-1300.
41. Mahoney T, Kuo YH, Topilow A et al. Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients. Arch Surg 2000;135:182-185.
42. Peake MD, Thompson S, Lowe D et al. Ageism in the management of lung cancer. Age Ageing 2003;32:171-177.
43. Feldman S. Please don't call me 'dear': older women's narratives of health care. Nurs Inq 1999;6:269-276.
44. Kubey RW. Television and aging: past, present, and future. Gerontologist 1980;20:16-35.
45. Zebrowitz LA, Montepare JM. Too young, too old, stigmatizing adolescents and elderly. In: Heatherton T, Kleck R, Hull M et al., eds. Stigma. New York: Guilford, 2000:334-373.
46. Levy BR. The inner self of the Japanese elderly: a defense against negative stereotypes of aging. Int J Aging Hum Dev 1999;48:131-144.
47. Levy B, Langer E. Aging free from negative stereotypes: successful memory in China and among the American deaf. J Pers Soc Psychol 1994;66:989-997.
48. Dale D. Poor prognosis in elderly patients with cancer: the role of bias and undertreatment. J Support Oncol 2003;1(suppl 2):11-17.
49. DeMichele A, Putt M, Zhang Y et al. Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients. Cancer 2003;97:2150-2159.
50. Samet J, Hunt WC, Key C et al. Choice of cancer therapy varies with age of patient. JAMA 1986;255:3385-3390.
51. Greenfield S, Blanco DM, Elashoff RM et al. Patterns of care related to age of breast cancer patients. JAMA 1987;257:2766-2770.
52. Grover SA, Cook EF, Adam J et al. Delayed diagnosis of gynecologic tumors in elderly women: relation to national medical practice patterns. Am J Med 1989;86:151-157.
53. Greenberg ER, Chute CG, Stukel T et al. Social and economic factors in the choice of lung cancer treatment. A population-based study in two rural states. N Engl J Med 1988;318:612-617.
54. Kong A, Barnett GO, Mosteller F et al. How medical professionals evaluate expressions of probability. N Engl J Med 1986;315:740-744.
55. Hunter CP, Frelick RW, Feldman AR et al. Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log. Cancer Treat Rep 1987;71:559-565.
56. Schleifer SJ, Bhardwaj S, Lebovits A et al. Predictors of physician nonadherence to chemotherapy regimens. Cancer 1991;67:945-951.
57. Obrist R, Honegger HP, Pichert G et al. Physicians' attitudes in the treatment of elderly cancer patients (pts) with aggressive NHL. Ann Oncol 1992;3(suppl 5).
58. Taylor KM, Margolese RG, Soskolne CL. Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med 1984;310:1363-1367.
59. Benson AB 3rd, Pregler JP, Bean JA et al. Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. J Clin Oncol 1991;9:2067-2075.
60. Kemeny MM, Peterson BL, Kornblith AB et al. Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol 2003;21:2268-2275.
61. Balducci L. The geriatric cancer patient: equal benefit from equal treatment (review). Cancer Control 2001;8(suppl 2):1-25; quiz 27-28.
62. Joel SP, Shah R, Slevin ML. Etoposide dosage and pharmacodynamics (review). Cancer Chemother Pharmacol 1994;34(suppl):S69-S75.
63. Zalcberg J, Kerr D, Seymour L et al. Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number. Tomudex International Study Group. Eur J Cancer 1998;34:1871-1875.
64. Zhu AX, Puchalski TA, Stanton VP Jr et al. Dihydropyrimidine dehydrogenase and thymidylate synthase polymorphisms and their association with 5-fluorouracil/leucovorin chemotherapy in colorectal cancer. Clin Colorectal Cancer 2004;3:225-234.
65. Ershler WB, Longo DL. Aging and cancer: issues of basic and clinical science. J Natl Cancer Inst 1997;89:1489-1497.
66. Wildiers H, Highley MS, de Bruijn EA et al. Pharmacology of anticancer drugs in the elderly population. Clin Pharmacokinet 2003;42:1213-1242.
67. Tulsky JA, Fischer GS, Rose MR et al. Opening the black box: how do physicians communicate about advance directives? Ann Intern Med 1998;129:441-449.
68. Hanson LC, Tulsky JA, Danis M. Can clinical interventions change care at the end of life? Ann Intern Med 1997;126:381-388.
69. Gillick MR. A broader role for advance medical planning. Ann Intern Med 1995;123:621-624.
70. Brett AS. Limitations of listing specific medical interventions in advance directives. JAMA 1991;266:825-828.
71. Rosenfeld KE, Wenger NS, Kagawa-Singer M. End-of-life decision making: a qualitative study of elderly individuals. J Gen Intern Med 2000;15:620-625.
72. Patrick DL, Pearlman RA, Starks HE et al. Validation of preferences for life-sustaining treatment: implications for advance care planning. Ann Intern Med 1997;127:509-517.
73. Pearlman RA, Cain KC, Patrick DL et al. Insights pertaining to patient assessments of states worse than death. J Clin Ethics 1993;4:33-41.
74. Doukas DJ, McCullough LB. The values history. The evaluation of the patient's values and advance directives. J Fam Pract 1991;32:145-153.
75. Danis M, Mutran E, Garrett JM et al. A prospective study of the impact of patient preferences on life-sustaining treatment and hospital cost. Crit Care Med 1996;24:1811-1817.
76. Murphy DJ, Burrows D, Santilli S et al. The influence of the probability of survival on patients' preferences regarding cardiopulmonary resuscitation. N Engl J Med 1994;330:545-549.
77. Schonwetter RS, Walker RM, Kramer DR et al. Resuscitation decision making in the elderly: the value of outcome data. J Gen Intern Med 1993;8:295-300.
78. Fried TR, Bradley EH, Towle VR et al. Understanding the treatment preferences of seriously ill patients. N Engl J Med 2002;346:1061-1066.
79. Somogyi-Zalud E, Zhong Z, Hamel MB et al. The use of life-sustaining treatments in hospitalized persons aged 80 and older. J Am Geriatr Soc 2002;50:930-934.
80. Resnick B, Andrews C. End-of-life treatment preferences among older adults: a nurse practitioner initiated intervention. J Am Acad Nurse Pract 2002;14:517-522.
81. Yellen SB, Cella DF, Leslie WT. Age and clinical decision making in oncology patients. J Natl Cancer Inst 1994;86:1766-1770.
82. Travis SS, Loving G, McClanahan L et al. Hospitalization patterns and palliation in the last year of life among residents in long-term care. Gerontologist 2001;41:153-160.
83. Extermann M, Albrand G, Chen H et al. Are older French patients as willing as older American patients to undertake chemotherapy? J Clin Oncol 2003;21:3214-3219.
84. Merriam-Webster OnLine. Merriam-Webster online dictionary. http://www.merriam-webster.com.
85. The AM, Hak T, Koeter G et al. Collusion in doctor-patient communication about imminent death: an ethnographic study. West J Med 2001;174:247-253.
86. Arnold L, Shue CK, Jones D. Implementation of geriatric education into the first and second years of a baccalaureate-MD degree program. Acad Med 2002;77:933-934.
87. Katz A, Conant JL, Inui T et al. A council of elders: creating a multivoiced dialogue in a community of care. Soc Sci Med 2000;50:851-860.
88. Busch-Devereaux E, Kemeny MM. Surgery in the elderly oncology patient. In: Hunter CP, Johnson, KA, Muss HB, eds. Cancer in the Elderly. New York: Marcel Dekker, Inc., 2000.